Table 2

Baseline characteristics of the 33 hypercholesterolemic subjects participating in both 8 wk intervention periods
Randomization groups Group AB Group BA Pa
  n 16 17
  Age (y) 49.7 ± 12.8 49.4 ± 13.9 0.91
  Females (n) 6 12
  Current smoking (%) 33.0 16.7
  Physical activity ≥ 2 h/wk (%) 66.7 66.7
Anthropometric data
  Body height (m) 1.7 ± 0.1 1.7 ± 0.1 0.44
  Body weight (kg) 84.2 ± 25.3 76.4 ± 14.4 0.30
  BMI (kg/m2) 28.8 ± 6.5 27.3 ± 5.4 0.48
  Body fat (kg) 24.3 ± 12.1 24.9 ± 9.0 0.86
Blood pressure
  Systolic BP (mm Hg) 143.9 ± 15.8 142.4 ± 17.3 0.81
  Diastolic BP (mm Hg) 87.9 ± 12.0 85.7 ± 9.6 0.56
  Pulse at rest (min-1) 69.6 ± 15.3 71.0 ± 13.6 0.78
Plasma parameters
  Total cholesterol (mmol/L) 6.14 ± 1.00 6.88 ± 1.16 0.06
  LDL cholesterol (mmol/L) 4.02 ± 1.09 4.69 ± 1.13 0.10
  HDL cholesterol (mmol/L) 1.33 ± 0.37 1.58 ± 0.49 0.11
  Triacylglyceroles (mmol/L) 2.03 ± 1.50 1.55 ± 0.79 0.28
  LDL:HDL cholesterol ratio 3.33 ± 1.43 3.30 ± 1.40 0.95
  Urea (mmol/L) 5.45 ± 1.37 4.58 ± 1.13 0.05
  hs-CRPb (mg/L) 1.83 ± 2.30 2.02 ± 2.07 0.84

Values are presented as mean ± standard deviation, number or percentage.

Abbreviation: Group AB subjects receiving LPI in the first intervention period; Group BA subjects receiving LPI in the second intervention period; LPI lupin protein isolate, BP blood pressure, hs-CRP high-sensitivity C-reactive protein.

aP-value is for differences between randomization groups using independent samples t-test.

bhs-CRP values of some participants had to be excluded due to a temporary inflammatory status at time of measurement; group AB; n = 10; group BA, n = 13.

Bähr et al.

Bähr et al. Nutrition Journal 2013 12:107   doi:10.1186/1475-2891-12-107

Open Data